Article
The in Vitro and in Vivo Antitumor Effect Associating With the Hippo-yap Signaling Pathway of Gallic Acid and Its Combination With Icotinib Hydrochloride on the Non-small Cell Lung Cancer Cellular and Xenograft Tumor-bearing Nude Mouse Models
2021-06-16
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) have been widely used as first-line therapy for patients with EGFR mutant non-small cell lung cancer (NSCLC). However, EGFR-TKIs treatment of NSCLC will inevitably produce acquired drug resistance. It greatly limits the therapeutic effect of TKI. Recent studies have found that some natural d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e58f19f6-aa2a-5fd0-84c2-bec7fbebec5c
- DOI
- 10.21203/rs.3.rs-618568/v1
